Cartesian Therapeutics, Inc. Common Stock

RNAC XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

190M

Short interest (May 15)

7.5%

Net Short (Jun 03 ): 0.0%

Borrow Fee

1.05%

↓ 27.4%

Available Shares

200K

↓ 50.1%

Price Chart

Company Overview

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001453687

Asset Type: CS

Market Data

Market Cap: $188,335,504

Employees: 75

Status: Active

Short Interest

Current Borrow Fee 1.05%

Range: 1.04% - 1.10%

Available Shares 200K

Range: 150K - 200K

Recent Changes

Fee Change: ↓ 0.7%

Available Change: ↓ 50.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime